OSU-02067
OSU-02067 is a selective 3-phosphoinositide-dependent protein kinase-1 (PDK-1) inhibitor (IC50=9 μM) . OSU-02067 is promising for research of solid tumors (e.g., prostate, breast, colorectal cancers) [1].
Product Specifications
CAS Number
618068-98-7
UNSPSC
12352005
Target
PDK-1
Related Pathways
PI3K/Akt/mTOR
Field of Research
Cancer
Smiles
O=S(N)(C1=CC=C(N2N=C(C(F)(F)F)C=C2C3=CC(C=CC4=C5C=CC=C4)=C5C=C3)C=C1)=O
Molecular Formula
C24H16F3N3O2S
Molecular Weight
467.46
References & Citations
[1]Zhu J, et al. From the cyclooxygenase-2 inhibitor celecoxib to a novel class of 3-phosphoinositide-dependent protein kinase-1 inhibitors. Cancer Res. 2004 Jun 15;64 (12) :4309-18. doi: 10.1158/0008-5472.CAN-03-4063. Erratum in: Cancer Res. 2019 Apr 1;79 (7) :1716.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRC-H953675-25MG 25 mg
N-Hydroxysuccinimidyl trans-4-Isopropylcyclohexanecarboxylate
Sign In for Pricing
View Details 
